O	0	10	Expression	Expression	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	19	EphA2	EphA2	NN	B-NP
O	20	23	and	and	CC	I-NP
O	24	25	E	E	NN	I-NP
O	25	26	-	-	HYPH	B-NP
O	26	34	cadherin	cadherin	NN	I-NP
O	35	37	in	in	IN	B-PP
B-Cancer	38	48	colorectal	colorectal	JJ	B-NP
I-Cancer	49	55	cancer	cancer	NN	I-NP
O	55	56	:	:	:	O
O	57	68	correlation	correlation	NN	B-NP
O	69	73	with	with	IN	B-PP
B-Cancer	74	80	cancer	cancer	NN	B-NP
O	81	91	metastasis	metastasis	NN	I-NP
O	91	92	.	.	.	O

O	94	102	Recently	Recently	RB	B-ADVP
O	102	103	,	,	,	O
O	104	118	overexpression	overexpression	NN	B-NP
O	119	121	of	of	IN	B-PP
O	122	127	EphA2	EphA2	NN	B-NP
O	127	128	,	,	,	O
O	129	130	a	a	DT	B-NP
O	131	137	member	member	NN	I-NP
O	138	140	of	of	IN	B-PP
O	141	144	the	the	DT	B-NP
O	145	148	Eph	Eph	NNP	I-NP
O	149	155	family	family	NN	I-NP
O	156	158	of	of	IN	B-PP
O	159	167	receptor	receptor	NN	B-NP
O	168	176	tyrosine	tyrosine	NN	I-NP
O	177	184	kinases	kinase	NNS	I-NP
O	184	185	,	,	,	O
O	186	189	has	have	VBZ	B-VP
O	190	194	been	be	VBN	I-VP
O	195	203	reported	report	VBN	I-VP
O	204	206	in	in	IN	B-PP
O	207	214	several	several	JJ	B-NP
B-Cancer	215	222	cancers	cancer	NNS	I-NP
O	222	223	.	.	.	O

O	224	231	Reduced	Reduce	VBN	B-NP
O	232	242	expression	expression	NN	I-NP
O	243	245	of	of	IN	B-PP
O	246	247	E	E	NN	B-NP
O	247	248	-	-	HYPH	B-NP
O	248	256	cadherin	cadherin	NN	I-NP
O	256	257	,	,	,	O
O	258	260	an	an	DT	B-NP
B-Immaterial_anatomical_entity	261	274	intercellular	intercellular	JJ	I-NP
O	275	283	adhesion	adhesion	NN	I-NP
O	284	292	molecule	molecule	NN	I-NP
O	293	295	of	of	IN	B-PP
B-Cell	296	306	epithelial	epithelial	JJ	B-NP
I-Cell	307	312	cells	cell	NNS	I-NP
O	312	313	,	,	,	O
O	314	317	has	have	VBZ	B-VP
O	318	322	been	be	VBN	I-VP
O	323	331	reported	report	VBN	I-VP
O	332	334	to	to	TO	I-VP
O	335	337	be	be	VB	I-VP
O	338	348	associated	associate	VBN	I-VP
O	349	353	with	with	IN	B-PP
O	354	364	aggressive	aggressive	JJ	B-NP
O	365	384	clinicopathological	clinicopathological	JJ	I-NP
O	385	395	phenotypes	phenotype	NNS	I-NP
O	396	398	in	in	IN	B-PP
O	399	406	various	various	JJ	B-NP
B-Cancer	407	414	cancers	cancer	NNS	I-NP
O	414	415	.	.	.	O

O	416	418	In	In	IN	B-PP
B-Cell	419	429	epithelial	epithelial	JJ	B-NP
I-Cell	430	435	cells	cell	NNS	I-NP
O	435	436	,	,	,	O
O	437	442	EphA2	EphA2	NN	B-NP
O	443	446	and	and	CC	I-NP
O	447	448	E	E	NN	I-NP
O	448	449	-	-	HYPH	B-NP
O	449	457	cadherin	cadherin	NN	I-NP
O	458	460	co	co	AFX	O
O	460	461	-	-	HYPH	O
O	461	469	localize	localize	VB	B-VP
O	470	472	to	to	TO	B-PP
O	473	478	sites	site	NNS	B-NP
O	479	481	of	of	IN	B-PP
B-Cellular_component	482	486	cell	cell	NN	B-NP
I-Cellular_component	486	487	-	-	HYPH	B-NP
I-Cellular_component	487	491	cell	cell	NN	I-NP
I-Cellular_component	492	499	contact	contact	NN	I-NP
O	499	500	,	,	,	O
O	501	504	and	and	CC	O
O	505	507	it	it	PRP	B-NP
O	508	511	has	have	VBZ	B-VP
O	512	516	been	be	VBN	I-VP
O	517	522	shown	show	VBN	I-VP
O	523	527	that	that	IN	B-SBAR
O	528	529	E	E	NN	B-NP
O	529	530	-	-	HYPH	O
O	530	538	cadherin	cadherin	NN	B-NP
O	539	548	regulates	regulate	VBZ	B-VP
O	549	554	EphA2	EphA2	NN	B-NP
O	554	555	.	.	.	O

O	556	560	This	This	DT	B-NP
O	561	566	study	study	NN	I-NP
O	567	572	aimed	aim	VBD	B-VP
O	573	575	to	to	TO	I-VP
O	576	583	clarify	clarify	VB	I-VP
O	584	587	the	the	DT	B-NP
O	588	600	relationship	relationship	NN	I-NP
O	601	608	between	between	IN	B-PP
O	609	612	the	the	DT	B-NP
O	613	623	expression	expression	NN	I-NP
O	624	626	of	of	IN	B-PP
O	627	630	the	the	DT	B-NP
O	631	636	EphA2	EphA2	NN	I-NP
O	637	640	and	and	CC	I-NP
O	641	642	E	E	NN	I-NP
O	642	643	-	-	HYPH	B-NP
O	643	651	cadherin	cadherin	NN	I-NP
O	652	660	proteins	protein	NNS	I-NP
O	661	664	and	and	CC	O
O	665	684	clinicopathological	clinicopathological	JJ	B-NP
O	685	700	characteristics	characteristic	NNS	I-NP
O	700	701	,	,	,	O
O	702	706	with	with	IN	B-PP
O	707	716	reference	reference	NN	B-NP
O	717	719	to	to	TO	B-PP
O	720	723	the	the	DT	B-NP
O	724	734	expression	expression	NN	I-NP
O	735	741	levels	level	NNS	I-NP
O	742	744	of	of	IN	B-PP
O	745	749	both	both	CC	O
O	750	755	EphA2	EphA2	NN	B-NP
O	756	759	and	and	CC	I-NP
O	760	761	E	E	NN	I-NP
O	761	762	-	-	HYPH	B-NP
O	762	770	cadherin	cadherin	NN	I-NP
O	770	771	,	,	,	O
O	772	774	in	in	IN	B-PP
O	775	783	patients	patient	NNS	B-NP
O	784	788	with	with	IN	B-PP
B-Cancer	789	799	colorectal	colorectal	JJ	B-NP
I-Cancer	800	806	cancer	cancer	NN	I-NP
O	806	807	.	.	.	O

O	808	810	We	We	PRP	B-NP
O	811	820	performed	perform	VBD	B-VP
O	821	840	immunohistochemical	immunohistochemical	JJ	B-NP
O	841	849	staining	staining	NN	I-NP
O	850	852	of	of	IN	B-PP
O	853	858	EphA2	EphA2	NN	B-NP
O	859	862	and	and	CC	I-NP
O	863	864	E	E	NN	I-NP
O	864	865	-	-	HYPH	B-NP
O	865	873	cadherin	cadherin	NN	I-NP
O	874	878	with	with	IN	B-PP
O	879	884	EphA2	EphA2	NN	B-NP
O	885	888	and	and	CC	I-NP
O	889	890	E	E	NN	I-NP
O	890	891	-	-	HYPH	B-NP
O	891	899	cadherin	cadherin	NN	I-NP
O	900	910	monoclonal	monoclonal	JJ	I-NP
O	911	921	antibodies	antibody	NNS	I-NP
O	922	924	in	in	IN	B-PP
B-Cancer	925	932	samples	sample	NNS	B-NP
O	933	937	from	from	IN	B-PP
O	938	941	194	194	CD	B-NP
B-Cancer	942	949	primary	primary	JJ	I-NP
I-Cancer	950	957	lesions	lesion	NNS	I-NP
O	958	960	of	of	IN	B-PP
B-Cancer	961	971	colorectal	colorectal	JJ	B-NP
I-Cancer	972	978	cancer	cancer	NN	I-NP
O	978	979	.	.	.	O

O	980	983	The	The	DT	B-NP
O	984	994	expression	expression	NN	I-NP
O	995	1000	level	level	NN	I-NP
O	1001	1003	of	of	IN	B-PP
O	1004	1009	EphA2	EphA2	NN	B-NP
O	1010	1013	had	have	VBD	B-VP
O	1014	1015	a	a	DT	B-NP
O	1016	1029	statistically	statistically	RB	I-NP
O	1030	1041	significant	significant	JJ	I-NP
O	1042	1054	relationship	relationship	NN	I-NP
O	1055	1059	with	with	IN	B-PP
B-Organ	1060	1065	liver	liver	NN	B-NP
O	1066	1076	metastasis	metastasis	NN	I-NP
O	1076	1077	,	,	,	O
B-Multi-tissue_structure	1078	1087	lymphatic	lymphatic	JJ	B-NP
I-Multi-tissue_structure	1088	1094	vessel	vessel	NN	I-NP
O	1095	1103	invasion	invasion	NN	I-NP
O	1104	1107	and	and	CC	O
O	1108	1116	clinical	clinical	JJ	B-NP
O	1117	1122	stage	stage	NN	I-NP
O	1123	1124	(	(	(	O
O	1124	1125	p	p	NN	B-NP
O	1125	1126	=	=	SYM	B-VP
O	1126	1127	0	0	CD	B-NP
O	1127	1128	.	.	SYM	I-NP
O	1128	1132	0477	0477	CD	I-NP
O	1132	1133	,	,	,	I-NP
O	1134	1135	0	0	CD	I-NP
O	1135	1136	.	.	.	I-NP
O	1136	1140	0316	0316	CD	I-NP
O	1141	1144	and	and	CC	I-NP
O	1145	1146	0	0	CD	I-NP
O	1146	1147	.	.	.	I-NP
O	1147	1151	0467	0467	CD	I-NP
O	1151	1152	,	,	,	O
O	1153	1165	respectively	respectively	RB	B-ADVP
O	1165	1166	)	)	)	O
O	1166	1167	.	.	.	O

O	1168	1170	In	In	IN	B-PP
O	1171	1179	addition	addition	NN	B-NP
O	1179	1180	,	,	,	O
O	1181	1184	the	the	DT	B-NP
O	1185	1195	positivity	positivity	NN	I-NP
O	1196	1200	rate	rate	NN	I-NP
O	1201	1203	of	of	IN	B-PP
O	1204	1209	EphA2	EphA2	NN	B-NP
O	1210	1213	was	be	VBD	B-VP
O	1214	1227	significantly	significantly	RB	B-ADJP
O	1228	1234	higher	high	JJR	I-ADJP
O	1235	1237	in	in	IN	B-PP
B-Cancer	1238	1245	primary	primary	JJ	B-NP
I-Cancer	1246	1253	lesions	lesion	NNS	I-NP
O	1254	1258	with	with	IN	B-PP
B-Multi-tissue_structure	1259	1264	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	1265	1269	node	node	NN	I-NP
O	1270	1280	metastasis	metastasis	NN	I-NP
O	1281	1285	than	than	IN	B-PP
O	1286	1288	in	in	IN	B-PP
O	1289	1294	those	those	DT	B-NP
O	1295	1302	without	without	IN	B-PP
O	1303	1313	metastasis	metastasis	NN	B-NP
O	1314	1315	(	(	(	O
O	1315	1316	p	p	NN	B-NP
O	1316	1317	=	=	SYM	B-VP
O	1317	1318	0	0	CD	B-NP
O	1318	1319	.	.	SYM	I-NP
O	1319	1323	0014	0014	CD	I-NP
O	1323	1324	)	)	)	O
O	1324	1325	.	.	.	O

O	1326	1333	However	However	RB	B-ADVP
O	1333	1334	,	,	,	O
O	1335	1338	the	the	DT	B-NP
O	1339	1349	expression	expression	NN	I-NP
O	1350	1355	level	level	NN	I-NP
O	1356	1358	of	of	IN	B-PP
O	1359	1360	E	E	NN	B-NP
O	1360	1361	-	-	HYPH	O
O	1361	1369	cadherin	cadherin	NN	B-NP
O	1370	1373	had	have	VBD	B-VP
O	1374	1376	an	an	DT	B-NP
O	1377	1384	inverse	inverse	JJ	I-NP
O	1385	1397	relationship	relationship	NN	I-NP
O	1398	1402	with	with	IN	B-PP
O	1403	1407	both	both	CC	O
O	1408	1423	differentiation	differentiation	NN	B-NP
O	1424	1429	level	level	NN	I-NP
O	1430	1432	of	of	IN	B-PP
O	1433	1436	the	the	DT	B-NP
B-Cancer	1437	1442	tumor	tumor	NN	I-NP
O	1443	1446	and	and	CC	O
B-Multi-tissue_structure	1447	1456	lymphatic	lymphatic	JJ	B-NP
I-Multi-tissue_structure	1457	1463	vessel	vessel	NN	I-NP
O	1464	1472	invasion	invasion	NN	I-NP
O	1473	1474	(	(	(	O
O	1474	1475	p	p	NN	B-NP
O	1475	1476	=	=	SYM	B-VP
O	1476	1477	0	0	CD	B-NP
O	1477	1478	.	.	SYM	I-NP
O	1478	1482	0430	0430	CD	I-NP
O	1483	1486	and	and	CC	I-NP
O	1487	1488	0	0	CD	I-NP
O	1488	1489	.	.	.	I-NP
O	1489	1493	0320	0320	CD	I-NP
O	1493	1494	,	,	,	O
O	1495	1507	respectively	respectively	RB	B-ADVP
O	1507	1508	)	)	)	O
O	1508	1509	.	.	.	O

O	1510	1521	Furthermore	Furthermore	RB	B-ADVP
O	1521	1522	,	,	,	O
O	1523	1524	a	a	DT	B-NP
O	1525	1536	significant	significant	JJ	I-NP
O	1537	1549	relationship	relationship	NN	I-NP
O	1550	1557	between	between	IN	B-PP
O	1558	1561	the	the	DT	B-NP
O	1562	1572	expression	expression	NN	I-NP
O	1573	1575	of	of	IN	B-PP
O	1576	1581	EphA2	EphA2	NN	B-NP
O	1582	1585	and	and	CC	I-NP
O	1586	1587	E	E	NN	I-NP
O	1587	1588	-	-	HYPH	B-NP
O	1588	1596	cadherin	cadherin	NN	I-NP
O	1597	1600	was	be	VBD	B-VP
O	1601	1609	observed	observe	VBN	I-VP
O	1609	1610	.	.	.	O

O	1611	1613	In	In	IN	B-PP
O	1614	1624	conclusion	conclusion	NN	B-NP
O	1624	1625	,	,	,	O
O	1626	1629	our	our	PRP$	B-NP
O	1630	1635	study	study	NN	I-NP
O	1636	1644	revealed	reveal	VBD	B-VP
O	1645	1649	that	that	IN	B-SBAR
O	1650	1653	the	the	DT	B-NP
O	1654	1668	overexpression	overexpression	NN	I-NP
O	1669	1671	of	of	IN	B-PP
O	1672	1677	EphA2	EphA2	NN	B-NP
O	1678	1685	protein	protein	NN	I-NP
O	1686	1688	in	in	IN	B-PP
B-Tissue	1689	1699	colorectal	colorectal	JJ	B-NP
I-Tissue	1700	1709	carcinoma	carcinoma	NN	I-NP
I-Tissue	1710	1716	tissue	tissue	NN	I-NP
O	1717	1727	correlates	correlate	VBZ	B-VP
O	1728	1735	closely	closely	RB	B-ADVP
O	1736	1740	with	with	IN	B-PP
B-Cancer	1741	1747	cancer	cancer	NN	B-NP
O	1748	1759	progression	progression	NN	I-NP
O	1760	1763	and	and	CC	O
O	1764	1776	hematogenous	hematogenous	JJ	B-NP
O	1777	1780	and	and	CC	I-NP
O	1781	1793	lymphogenous	lymphogenous	JJ	I-NP
O	1794	1804	metastasis	metastasis	NN	I-NP
O	1804	1805	,	,	,	O
O	1806	1816	suggesting	suggest	VBG	B-VP
O	1817	1821	that	that	IN	B-SBAR
O	1822	1826	both	both	CC	O
O	1827	1832	EphA2	EphA2	NN	B-NP
O	1833	1836	and	and	CC	I-NP
O	1837	1838	E	E	NN	I-NP
O	1838	1839	-	-	HYPH	B-NP
O	1839	1847	cadherin	cadherin	NN	I-NP
O	1848	1851	may	may	MD	B-VP
O	1852	1856	play	play	VB	I-VP
O	1857	1859	an	an	DT	B-NP
O	1860	1869	important	important	JJ	I-NP
O	1870	1874	role	role	NN	I-NP
O	1875	1877	in	in	IN	B-PP
B-Cancer	1878	1883	tumor	tumor	NN	B-NP
O	1884	1894	metastasis	metastasis	NN	I-NP
O	1895	1897	in	in	IN	B-PP
B-Cancer	1898	1908	colorectal	colorectal	JJ	B-NP
I-Cancer	1909	1915	cancer	cancer	NN	I-NP
O	1915	1916	.	.	.	O

